创新医疗：博灵脑机产品赛博灵科AC5已于2025年10月正式上市销售，2025年共实现收入11.40万元

Core Viewpoint - Innovation Medical (002173) has experienced a significant stock price increase, with a cumulative deviation of over 20% in closing prices over three consecutive trading days [1] Group 1: Company Performance - The company's subsidiary, Boling Brain Machine, launched the Cyberlink AC5 product in October 2025, generating revenue of 114,000 yuan in 2025 [1] - The Cyberlink AM5 product has completed multi-center clinical trials but has not generated revenue in 2025 [1] - The operating losses for Boling Brain Machine were 6.60 million yuan in 2023 and 8.66 million yuan in 2024 [1]